Skip to Main Content

U of T Spinoff Company Inks its Third Agreement

University of Toronto spinoff company Interface Biologics Inc. has announced the signing of an evaluation and exclusive license option agreement with Fresenius Medical Care, the world’s largest

Artery-on-a-Chip Studies Heart Disease

Professor Axel Guenther (MIE, IBBME) and colleagues have developed a microfluidic platform on which fragile blood vessels can be fixed, allowing the factors that promote and sustain cardiovascular

Two Engineering Professors receive McLean Awards

By Carolyn Farrell Congratulations to Professors Baochun Li (ECE) and Yu Sun (MIE/IBBME), who received the University of Toronto’s McLean Awards for 2009 and 2010. This highly competitive award,